Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 16
1995 26
1996 35
1997 46
1998 49
1999 68
2000 50
2001 88
2002 117
2003 112
2004 99
2005 94
2006 106
2007 110
2008 103
2009 101
2010 116
2011 92
2012 78
2013 80
2014 76
2015 54
2016 45
2017 47
2018 47
2019 26
2020 32
2021 30
2022 33
2023 21
2024 14

Search Results

1,783 results

Results by year

Filters applied: . Clear all
Page 1
Neurotoxicity of MDMA: Main effects and mechanisms.
Costa G, Gołembiowska K. Costa G, et al. Exp Neurol. 2022 Jan;347:113894. doi: 10.1016/j.expneurol.2021.113894. Epub 2021 Oct 13. Exp Neurol. 2022. PMID: 34655576 Review.
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.
Mitchell JM, Bogenschutz M, Lilienstein A, Harrison C, Kleiman S, Parker-Guilbert K, Ot'alora G M, Garas W, Paleos C, Gorman I, Nicholas C, Mithoefer M, Carlin S, Poulter B, Mithoefer A, Quevedo S, Wells G, Klaire SS, van der Kolk B, Tzarfaty K, Amiaz R, Worthy R, Shannon S, Woolley JD, Marta C, Gelfand Y, Hapke E, Amar S, Wallach Y, Brown R, Hamilton S, Wang JB, Coker A, Matthews R, de Boer A, Yazar-Klosinski B, Emerson A, Doblin R. Mitchell JM, et al. Nat Med. 2021 Jun;27(6):1025-1033. doi: 10.1038/s41591-021-01336-3. Epub 2021 May 10. Nat Med. 2021. PMID: 33972795 Free PMC article. Clinical Trial.
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.
Mitchell JM, Ot'alora G M, van der Kolk B, Shannon S, Bogenschutz M, Gelfand Y, Paleos C, Nicholas CR, Quevedo S, Balliett B, Hamilton S, Mithoefer M, Kleiman S, Parker-Guilbert K, Tzarfaty K, Harrison C, de Boer A, Doblin R, Yazar-Klosinski B; MAPP2 Study Collaborator Group. Mitchell JM, et al. Nat Med. 2023 Oct;29(10):2473-2480. doi: 10.1038/s41591-023-02565-4. Epub 2023 Sep 14. Nat Med. 2023. PMID: 37709999 Free PMC article. Clinical Trial.
Equasy revisited.
Young AH. Young AH. J Psychopharmacol. 2021 May;35(5):499-500. doi: 10.1177/02698811211012604. Epub 2021 May 3. J Psychopharmacol. 2021. PMID: 33938311 No abstract available.
Oxytocin in response to MDMA provocation test in patients with arginine vasopressin deficiency (central diabetes insipidus): a single-centre, case-control study with nested, randomised, double-blind, placebo-controlled crossover trial.
Atila C, Holze F, Murugesu R, Rommers N, Hutter N, Varghese N, Sailer CO, Eckert A, Heinrichs M, Liechti ME, Christ-Crain M. Atila C, et al. Lancet Diabetes Endocrinol. 2023 Jul;11(7):454-464. doi: 10.1016/S2213-8587(23)00120-1. Epub 2023 May 13. Lancet Diabetes Endocrinol. 2023. PMID: 37192642 Clinical Trial.
MDMA related neuro-inflammation and adenosine receptors.
Kermanian F, Seghatoleslam M, Mahakizadeh S. Kermanian F, et al. Neurochem Int. 2022 Feb;153:105275. doi: 10.1016/j.neuint.2021.105275. Epub 2022 Jan 3. Neurochem Int. 2022. PMID: 34990730 Review.
Making a medicine out of MDMA.
Sessa B, Nutt D. Sessa B, et al. Br J Psychiatry. 2015 Jan;206(1):4-6. doi: 10.1192/bjp.bp.114.152751. Br J Psychiatry. 2015. PMID: 25561485
1,783 results